Navigation Links
Escherichia coli bacteria transferring between humans and mountain gorillas
Date:11/24/2008

Bwindi, Uganda November 24, 2008 A new study finds that mountain gorillas are at increased risk of acquiring gastrointestinal microbes, such as Escherichia Coli, from humans. The study, published in Conservation Biology, examines the exchange of digestive system bacteria between humans, mountain gorillas and domestic animals with overlapping habitats.

The findings show the presence of identical, clinically-resistant bacteria, in gorillas, which implies that antibiotic resistant bacteria or resistance-conferring genetic elements are transferring from humans to gorillas. Gorilla populations that are the subject of research and tourism are particularly vulnerable.

It has been observed elsewhere that apes that are focus of research or tourism apes could be entry points for pathogens into the ape population. In rural Uganda, for example, antibiotics are easily obtained over-the-counter and may not always be used appropriately as evidenced by high rates of antibiotic resistance in bacteria from people in rural Uganda.

The results further show that even in well-managed situations, mountain gorillas may be at increased risk of pathogen exchange with humans and domestic animals, and preventing direct contact between people and mountain gorillas may not be sufficient for eliminating microbial exchange.

Other actions may be needed, such as encouraging hand washing before and after entering the forest, discouraging human defecation in the forest and mandating the wearing of aerosol-limiting face masks for people entering ape habitats.

Antibiotic resistance is an emerging problem in humans, and the presence of resistant bacteria in gorillas suggests that targeted interventions are needed to ensure natural disease resistance and overall health among native gorilla populations.


'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related biology news :

1. Scientists build roach motel for nasty bugs of the bacterial variety
2. Scientists present moving theory behind bacterial decision-making
3. Scripps research scientists identify blood component that turns bacteria virulent
4. How do bacteria swim? Brown physicists explain
5. Caltech researchers get first 3-D glimpse of bacterial cell-wall architecture
6. New bacteria discovered in raw milk
7. Shifts in soil bacterial populations linked to wetland restoration success
8. Battling bacteria in the blood: Researchers tackle deadly infections
9. Nature study demonstrates that bacterial clotting depends on clustering
10. Bacteria manage perfume oil production from grass
11. Predatory bacterial swarm uses rippling motion to reach prey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
(Date:6/29/2015)... June 24, 2015 Research ... the "Latin America Biomedical Sensors Market - Growth, ... The Latin America Biomedical Sensors market is ... of 2.04% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... CITY , Jan. 24, 2013 /PRNewswire-iReach/ -- Amiigo, ... has developed a new device for gesture recognition and ... that uses accelerometers and machine learning algorithms to automatically ... device knows if users are using the elliptical trainer ...
... than geologists previously thought, according to new research results. ... put very small samples of peridotite, rock derived from Earth,s ... found that the rock can and does liquify, at least ... deep as 250 kilometers down in the mantle beneath the ...
... leading experts will meet today in Brussels, Belgium, to ... research and the key findings of FLAVIOLA an ... health benefits and potential applications. Members of the FLAVIOLA ... researchers to review the outcomes of FLAVIOLA,s research and ...
Cached Biology News:Amiigo Unveils Fitness Tracker That Knows What Exercise You're Performing 2Magma in Earth's mantle forms deeper than once thought 2Magma in Earth's mantle forms deeper than once thought 3Recent breakthroughs in cocoa flavanol research discussed by European research consortium and expert panel 2
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/29/2015)... , July 30, 2015 ... santé, publie ses résultats pour le premier semestre ... commente les résultats. Visionner l,interview vidéo ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de l,interview ... - Moteurs de croissance - Diabète ...
(Date:7/29/2015)... 2015  HealthSouth Corporation (NYSE: HLS ... post-acute healthcare services, offering both facility-based and home-based ... for the second quarter ended June 30, 2015. ... strong volume growth in both segments and an ... Grinney, President and Chief Executive Officer of HealthSouth. ...
(Date:7/29/2015)... Inc., an early stage biotech startup based on perinatal ... the Musculoskeletal Transplant Foundation of Edison NJ ... round of development of the proprietary AmnioCept™ product line ... AmnioChor,s technology allows cryopreservation of the amniotic membrane of ... those tissues. Amnion is a well-established source of multipotent ...
Breaking Biology Technology:Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17
... ANDS ) today announced that patient dosing has ... oral TLR7 agonist prodrug, in,patients with advanced solid tumors. ... to identify pharmacologically active doses,and preliminary antitumor activity as ... II trials., The Phase I trial is a ...
... Co., Ltd. (President:,Dr. Yuzuru Matsuda) announced that Kyowa ... U.S. subsidiary, received on February 25,2008 (local time) ... and Drug,Administration (FDA) for istradefylline (KW-6002), its investigational ... the not approvable letter FDA expressed concern if ...
... at North Carolina State University have demonstrated that ... chemically different so-called Janus particles will ... field is applied to liquid surrounding the particles. ... the Feb. 8, 2008, edition of Physical Review ...
Cached Biology Technology:Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 2Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 3Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 4Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002) 2'2-faced' particles act like tiny submarines 2